Literature DB >> 3527843

The measurement and validation of the nonsteady-state rates of C-peptide appearance in the dog.

T Morishima, S Pye, K Polonsky, J Radziuk.   

Abstract

In order to verify the calculation of nonsteady rates of secretion of C-peptide, dog C-peptide was infused into 5 normal conscious dogs at varying rates. Using the decay curve obtained following a preliminary injection of C-peptide in each animal, concentrations during the infusion, and mathematical deconvolution, the rate of appearance of the C-peptide was calculated. This rate was within 12% of the infusion rates, with 94% of the C-peptide infused recovered in the calculation. The metabolic clearance of C-peptide was calculated to be 10.1 +/- 1.0 ml/min following both its injection and constant infusion. In conclusion, within the limits of the errors determined, C-peptide and therefore insulin secretion can be calculated on a continuous basis under nonsteady-state conditions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3527843     DOI: 10.1007/bf00506536

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  31 in total

1.  Circulating serum C-peptide. A brief review of diagnostic implications.

Authors:  D L Horwitz; H Kuzuya; A H Rubenstein
Journal:  N Engl J Med       Date:  1976-07-22       Impact factor: 91.245

2.  Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood.

Authors:  D L Horwitz; J I Starr; M E Mako; W G Blackard; A H Rubenstein
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

3.  C-peptide metabolism and the liver.

Authors:  C Kühl; O K Faber; P Hornnes; S L Jensen
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

4.  C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog.

Authors:  K S Polonsky; W Pugh; J B Jaspan; D M Cohen; T Karrison; H S Tager; A H Rubenstein
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

5.  Removal of insulin by perfused rat liver: effect of concentration.

Authors:  C E Mondon; J M Olefsky; C B Dolkas; G M Reaven
Journal:  Metabolism       Date:  1975-02       Impact factor: 8.694

6.  Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal man.

Authors:  W Waldhäusl; P Bratusch-Marrain; S Gasic; A Korn; P Nowotny
Journal:  Diabetologia       Date:  1979-10       Impact factor: 10.122

7.  Hepatic disposal of biosynthetic human insulin and porcine C-peptide in humans.

Authors:  P R Bratusch-Marrain; W K Waldhäusl; S Gasić; A Hofer
Journal:  Metabolism       Date:  1984-02       Impact factor: 8.694

8.  Insulin production rate, hepatic insulin retention and splanchnic carbohydrate metabolism after oral glucose ingestion in hyperinsulinaemic Type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  W Waldhäusl; P Bratusch-Marrain; S Gasić; A Korn; P Nowotny
Journal:  Diabetologia       Date:  1982-07       Impact factor: 10.122

9.  Differences in the hepatic and renal extraction of insulin and glucagon in the dog: evidence for saturability of insulin metabolism.

Authors:  K Polonsky; J Jaspan; D Emmanouel; K Holmes; A R Moossa
Journal:  Acta Endocrinol (Copenh)       Date:  1983-03

10.  Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior.

Authors:  R P Eaton; R C Allen; D S Schade; K M Erickson; J Standefer
Journal:  J Clin Endocrinol Metab       Date:  1980-09       Impact factor: 5.958

View more
  2 in total

1.  Modeling nonsteady-state metabolism from arteriovenous data.

Authors:  Erica Manesso; Gianna M Toffolo; Rita Basu; Robert A Rizza; Claudio Cobelli
Journal:  IEEE Trans Biomed Eng       Date:  2010-12-03       Impact factor: 4.538

2.  C-peptide enhances glucagon secretion in response to hyperinsulinemia under euglycemic and hypoglycemic conditions.

Authors:  Mary Courtney Moore; Shana O Warner; Yufei Dai; Nicole Sheanon; Marta Smith; Ben Farmer; Rebecca L Cason; Alan D Cherrington; Jason J Winnick
Journal:  JCI Insight       Date:  2021-06-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.